Precision Medicine Market is estimated to reach US$ 150.55 Bn by 2029, growing at a CAGR of 9.25% during the forecasted period and was valued to have US$ 81.04 Bn in 2022.COVID-19 impact on market:
COVID-19 has the potential to have three major effects on the global economy: directly impacting production and demand, causing supply chain and market disruption, and having a financial impact on businesses and financial markets. Our analysts, who are monitoring the situation throughout the world, believe that the market would provide producers with lucrative opportunities following the COVID-19 dilemma.To know about the Research Methodology :- Request Free Sample Report
Precision Medicine Market Definition:
The Precision medicine also term 'personalized medicine' are designed for particular groups of patients and refers to the tailoring of medical treatment to optimize efficiency or therapeutic benefit, that allows physicians to adopt treatments that are more likely to relief patients based on the genetic understanding of their disease. Precision medicine also reduces the cost of treatment by reducing repetitive intake of medicine and diminishing the side-effects allied with them.Precision Medicine Market Dynamics:
The report estimates the growth rate of Precision Medicine Market and offers in-depth insights on market dynamics, drivers, restraints, challenges and threats till 2029. The complete information is based on primary and secondary research carried out in all the regions covered in the report. The growth of the Precision Medicine Market is evolving mainly because of increasing genome sequencing, New technologies like gene therapy and investments in precision medicine research and (R&D) by the major players also propelled the growth of the precision medicine market in the world, growing cancer prevalence and chronic infection and different (ADR), initiate the market growth, application of Nanomedicines can change disease managing for targeted drug delivery. Hence, reducing adverse side effects, growing government funding in precision medicine initiatives and partnerships among software companies and pharmaceutical helps to drive the growth of the market. However, Developing accurate precision medicine at reasonable values can limit the growth of the market moreover, uneven infrastructure development across the region which becomes a challenging factor for developing countries for the growth of the precision medicine market and the shortage of skilled IT specialists in healthcare are anticipating to restrain market growth to a certain extent in the coming years.Precision Medicine Market Recent industry developments:
In May 2018, Foundation Medicine proclaimed approval for Advanced Diagnostic Laboratory Test (ADLT) for Foundation One CDx for escalating its existing product portfolio. In October 2018, Qiagen declared its launch of innovative RNA-seq library research solutions for next-generation sequencing. Advancements in pharmacogenomics, Pharmacogenomics has the largest market share (24%) followed by genomics. contributes to maintaining the efficacy of a drug with the help of genetic evidence of persons. The genomics market is also predictable to grow at the highest CAGR of 13.67% during 2022–2029. Furthermore, growing biopharmaceutical players to treat disease disorder like, cancer will drive the market growth positively.Precision Medicine Market Segment Analysis:
The report covers the brief analytical segments of the Precision Medicine Market thereby providing a wider view at the macro as well as micro levels. Based on application, Increasing incidence of cancer globally is likely to hold the major share for the treatment of cancers. Presently, several types of research and genetic tests are going on to develop Precision Medicine based on the patients. Precision medicine delivers a procedure to treat the patient based on the type of cancer, age, sex, adverse effect and other factors. Cancer detection is important for the physician to detect best-suited therapy to treat the person.In terms of end-use, Pharma & Biotech Companies estimated as the largest segment and valued to be around USD 24.2 Bn in 2022. The growth is accelerated by the availability of innovative techniques with next-generation sequencing (NGS) for the recognition of drug-related genetic changes. Moreover, major players are involved in several investment programs for market growth.
Regional analysis
Geographically, North America dominated the growth of Precision Medicine Market with the largest share of 43%, followed by Europe with a 26% share and is expected to projected to reach US$ XX Bn by 2029, with a CAGR of XX% during the forecast period. This is attributed to promising government initiatives, the presence of well-developed healthcare infrastructure and the occurrence of cancer combined with the growing researches for the development of biomarkers within the region such as the US and Canada. Also, an increasing number of product approvals, and rising awareness regarding the benefits of precision medicine in the region. Asia-Pacific is estimated to be the fastest-growing region with the highest CAGR of 11.5% during the forecast period.Global Precision Medicine Market Competitive Analysis:
The competitive landscape section in the Precision Medicine Market highly fragmented and the offers various strategies such as agreements, new product launches, partnerships expansions, acquisitions, joint ventures, and other crucial aspects to lessen the competitive in the market. For instance, in October 2018, Microsoft Genomics merge partnered with Eagle Genomics to tackle the challenges of the genomics. The goal of the collaboration was to introduce the power and scale of the cloud to precision medicine, through the creation of fundamental research. Moreover, in January 2018, to accelerate the growth in the cancer segment, F. Hoffmann La Roche Ltd collaborated with Syapse. The objective of the report is to present a comprehensive analysis of the Global Precision Medicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding global market dynamics, structure by analyzing the market segments and projects the global market size. Clear representation of competitive analysis of key players By Technology Type, price, financial position, Product portfolio, growth strategies, and regional presence in the global market make the report investor’s guideScope of the Global Precision Medicine Market : Inquire before buying
Global Precision Medicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 81.04 Bn. Forecast Period 2023 to 2029 CAGR: 9.25% Market Size in 2029: US $ 150.55 Bn. Segments Covered: by Product types Instruments Consumables Services by Technology Type Transcriptomics Genomic Sequencing Epigenomics Bioinformatics Drug Discovery Companion Diagnostics Big Data Analytics Software Other Technologies by Sequencing Technology type Ion Semiconductor Sequencing Pyrosequencing Single Molecule Real Time Sequencing Chain Termination Sequencing Sequencing by Synthesis Sequencing by Ligation Nanopore Sequencing by Application Type Oncology Immunology CNS Respiratory Neurosciences Infections Pharmacogenomics Rare Diseases Other by End User Pharma & Biotech Companies Diagnostic Tool Companies Big Data Companies Clinical Laboratories Healthcare Providers Research Centers and Academic Institutes Other Global Precision Medicine Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)key Players
1. ASEBIO 2. Biocrates Life Sciences AG 3. DxTerity Diagnostics Inc. 4. F. Hoffmann-La Roche Ltd 5. FOUNDATION MEDICINE 6. Intomics 7. Laboratory Corporation of America Holdings 8. Menarini Silicon Biosystems 9. NanoString Technologies, Inc 10. NeoGenomics Laboratories 11. Novartis AG 12. Pfizer Inc 13. QIAGEN 14. Quest Diagnostics Incorporated 15. Tepnel Pharma Services (Hologic Inc.) 16. Teva Pharmaceutical 17. Randox Laboratories 18. Biomrieux Sa 19. Abbott Laboratories 20. Intel Corporation 21. Cepheid Frequently Asked Questions: 1. Which region has the largest share in Global Precision Medicine Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Precision Medicine Market? Ans: The Global Precision Medicine Market is growing at a CAGR of 9.25% during forecasting period 2023-2029. 3. What segments are covered in Global Precision Medicine market? Ans: Precision Medicine Market is segmented into product type, technology type, sequencing technology type, application, end user and region. 4. Who are the key players in Global Precision Medicine market? Ans: The important key players in the Precision Medicine Market are – ASEBIO Biocrates Life Sciences AG, DxTerity Diagnostics Inc., F. Hoffmann-La Roche Ltd, FOUNDATION MEDICINE, Intomics, Menarini Silicon Biosystems, NanoString Technologies, Inc, NeoGenomics Laboratories, Novartis AG, Pfizer Inc, QIAGEN, Tepnel Pharma Services, Teva Pharmaceutical 5. What is the study period of this market? Ans: The Global Precision Medicine Market is studied from 2022 to 2029.
Global Precision Medicine Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Precision Medicine Market size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Precision Medicine Market Analysis and Forecast 6.1. Precision Medicine Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Precision Medicine Market Analysis and Forecast, By Product types 7.1. Introduction and Definition 7.2. Key Findings 7.3. Precision Medicine Market Value Share Analysis, By Product types 7.4. Precision Medicine Market Size (US$ Bn) Forecast, By Product types 7.5. Precision Medicine Market Analysis, By Product types 7.6. Precision Medicine Market Attractiveness Analysis, By Product types 8. Global Precision Medicine Market Analysis and Forecast, By Technology Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Precision Medicine Market Value Share Analysis, By Technology Type 8.4. Precision Medicine Market Size (US$ Bn) Forecast, By Technology Type 8.5. Precision Medicine Market Analysis, By Technology Type 8.6. Precision Medicine Market Attractiveness Analysis, By Technology Type 9. Global Precision Medicine Market Analysis and Forecast, By Sequencing Technology type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Precision Medicine Market Value Share Analysis, By Sequencing Technology type 9.4. Precision Medicine Market Size (US$ Bn) Forecast, By Sequencing Technology type 9.5. Precision Medicine Market Analysis, By Sequencing Technology type 9.6. Precision Medicine Market Attractiveness Analysis, By Sequencing Technology type 10. Global Precision Medicine Market Analysis and Forecast, By Application Type 10.1. Introduction and Definition 10.2. Key Findings 10.3. Precision Medicine Market Value Share Analysis, By Application Type 10.4. Precision Medicine Market Size (US$ Bn) Forecast, By Application Type 10.5. Precision Medicine Market Analysis By Application Type 10.6. Precision Medicine Market Attractiveness Analysis, By Application Type 11. Global Precision Medicine Market Analysis and Forecast, By End User 11.1. Introduction and Definition 11.2. Key Findings 11.3. Precision Medicine Market Value Share Analysis, By End User 11.4. Precision Medicine Market Size (US$ Bn) Forecast, By End User 11.5. Precision Medicine Market Analysis By End User 11.6. Precision Medicine Market Attractiveness Analysis, By End User 12. Global Precision Medicine Market Analysis, by Region 12.1. Precision Medicine Market Value Share Analysis, by Region 12.2. Precision Medicine Market Size (US$ Bn) Forecast, by Region 12.3. Precision Medicine Market Attractiveness Analysis, by Region 13. North America Precision Medicine Market Analysis 13.1. Key Findings 13.2. North America Precision Medicine Market Overview 13.3. North America Precision Medicine Market Value Share Analysis, By Product types 13.4. North America Precision Medicine Market Forecast, By Product types 13.4.1. Instruments 13.4.2. Consumables 13.4.3. Services 13.5. North America Precision Medicine Market Value Share Analysis, By Technology type 13.6. North America Precision Medicine Market Forecast, By Technology Type 13.6.1. Transcriptomics 13.6.2. Genomic Sequencing 13.6.3. Epigenomics 13.6.4. Bioinformatics 13.6.5. Drug Discovery 13.6.6. Companion Diagnostics 13.6.7. Big Data Analytics Software 13.6.8. Other Technologies 13.7. North America Precision Medicine Market Value Share Analysis, By Sequencing Technology type 13.8. North America Precision Medicine Market Forecast, By Sequencing Technology type 13.8.1. Ion Semiconductor Sequencing 13.8.2. Pyrosequencing 13.8.3. Single Molecule Real Time Sequencing 13.8.4. Chain Termination Sequencing 13.8.5. Sequencing by Synthesis 13.8.6. Sequencing by Ligation 13.8.7. Nanopore Sequencing 13.9. North America Precision Medicine Market Value Share Analysis, By Application Type 13.10. North America Precision Medicine Market Forecast, By Application Type 13.10.1. Oncology 13.10.2. Immunology 13.10.3. CNS 13.10.4. Respiratory 13.10.5. Neurosciences 13.10.6. Infections 13.10.7. Pharmacogenomics 13.10.8. Rare Diseases 13.10.9. Other 13.11. North America Precision Medicine Market Value Share Analysis, By End User 13.12. North America Precision Medicine Market Forecast, By End User 13.12.1. Pharma & Biotech Companies 13.12.2. Diagnostic Tool Companies 13.12.3. Big Data Companies 13.12.4. Clinical Laboratories 13.12.5. Healthcare Providers 13.12.6. Research Centers and Academic Institutes 13.12.7. Other 13.13. North America Precision Medicine Market Value Share Analysis, by Country 13.14. North America Precision Medicine Market Forecast, by Country 13.14.1. U.S. 13.14.2. Canada 13.15. North America Precision Medicine Market Analysis, by Country 13.16. U.S. Precision Medicine Market Forecast, By Product types 13.16.1. Instruments 13.16.2. Consumables 13.16.3. Services 13.17. U.S. Precision Medicine Market Forecast, By Technology Type 13.17.1. Transcriptomics 13.17.2. Genomic Sequencing 13.17.3. Epigenomics 13.17.4. Bioinformatics 13.17.5. Drug Discovery 13.17.6. Companion Diagnostics 13.17.7. Big Data Analytics Software 13.17.8. Other Technologies 13.18. U.S. Precision Medicine Market Forecast, By Sequencing Technology type 13.18.1. Ion Semiconductor Sequencing 13.18.2. Pyrosequencing 13.18.3. Single Molecule Real Time Sequencing 13.18.4. Chain Termination Sequencing 13.18.5. Sequencing by Synthesis 13.18.6. Sequencing by Ligation 13.18.7. Nanopore Sequencing 13.19. U.S. Precision Medicine Market Forecast, By Application Type 13.19.1. Oncology 13.19.2. Immunology 13.19.3. CNS 13.19.4. Respiratory 13.19.5. Neurosciences 13.19.6. Infections 13.19.7. Pharmacogenomics 13.19.8. Rare Diseases 13.19.9. Other 13.20. U.S. Precision Medicine Market Forecast, By End User 13.20.1. Pharma & Biotech Companies 13.20.2. Diagnostic Tool Companies 13.20.3. Big Data Companies 13.20.4. Clinical Laboratories 13.20.5. Healthcare Providers 13.20.6. Research Centers and Academic Institutes 13.20.7. Other 13.21. Canada Precision Medicine Market Forecast, By Product types 13.21.1. Instruments 13.21.2. Consumables 13.21.3. Services 13.22. Canada Precision Medicine Market Forecast, By Technology Type 13.22.1. Transcriptomics 13.22.2. Genomic Sequencing 13.22.3. Epigenomics 13.22.4. Bioinformatics 13.22.5. Drug Discovery 13.22.6. Companion Diagnostics 13.22.7. Big Data Analytics Software 13.22.8. Other Technologies 13.23. Canada Precision Medicine Market Forecast, By Sequencing Technology type 13.23.1. Ion Semiconductor Sequencing 13.23.2. Pyrosequencing 13.23.3. Single Molecule Real Time Sequencing 13.23.4. Chain Termination Sequencing 13.23.5. Sequencing by Synthesis 13.23.6. Sequencing by Ligation 13.23.7. Nanopore Sequencing 13.24. Canada Transplantation Market Forecast, By Application Type 13.24.1. Oncology 13.24.2. Immunology 13.24.3. CNS 13.24.4. Respiratory 13.24.5. Neurosciences 13.24.6. Infections 13.24.7. Pharmacogenomics 13.24.8. Rare Diseases 13.24.9. Other 13.25. Canada Transplantation Market Forecast, By End User 13.25.1. Pharma & Biotech Companies 13.25.2. Diagnostic Tool Companies 13.25.3. Big Data Companies 13.25.4. Clinical Laboratories 13.25.5. Healthcare Providers 13.25.6. Research Centers and Academic Institutes 13.25.7. Other 13.26. North America Precision Medicine Market Attractiveness Analysis 13.26.1. By Product types 13.26.2. By Technology Type 13.26.3. By Sequencing Technology type 13.26.4. By Application Type 13.26.5. By End User 13.27. PEST Analysis 13.28. Key Trends 13.29. Key Developments 14. Europe Precision Medicine Market Analysis 14.1. Key Findings 14.2. Europe Precision Medicine Market Overview 14.3. Europe Precision Medicine Market Value Share Analysis, By Product types 14.4. Europe Precision Medicine Market Forecast, By Product types 14.4.1. Instruments 14.4.2. Consumables 14.4.3. Services 14.5. Europe Precision Medicine Market Value Share Analysis, By Technology Type 14.6. Europe Precision Medicine Market Forecast, By Technology Type 14.6.1. Transcriptomics 14.6.2. Genomic Sequencing 14.6.3. Epigenomics 14.6.4. Bioinformatics 14.6.5. Drug Discovery 14.6.6. Companion Diagnostics 14.6.7. Big Data Analytics Software 14.6.8. Other Technologies 14.7. Europe Precision Medicine Market Value Share Analysis, By Sequencing Technology type 14.8. Europe Precision Medicine Market Forecast, By Sequencing Technology type 14.8.1. Ion Semiconductor Sequencing 14.8.2. Pyrosequencing 14.8.3. Single Molecule Real Time Sequencing 14.8.4. Chain Termination Sequencing 14.8.5. Sequencing by Synthesis 14.8.6. Sequencing by Ligation 14.8.7. Nanopore Sequencing 14.9. Europe Precision Medicine Market Value Share Analysis, By Application Type 14.10. Europe Precision Medicine Market Forecast, By Application Type 14.10.1. Oncology 14.10.2. Immunology 14.10.3. CNS 14.10.4. Respiratory 14.10.5. Neurosciences 14.10.6. Infections 14.10.7. Pharmacogenomics 14.10.8. Rare Diseases 14.10.9. Other 14.11. Europe Precision Medicine Market Value Share Analysis, By End User 14.12. Europe Precision Medicine Market Forecast, By End User 14.12.1. Pharma & Biotech Companies 14.12.2. Diagnostic Tool Companies 14.12.3. Big Data Companies 14.12.4. Clinical Laboratories 14.12.5. Healthcare Providers 14.12.6. Research Centers and Academic Institutes 14.12.7. Other 14.13. Europe Precision Medicine Market Value Share Analysis, by Country 14.14. Europe Precision Medicine Market Forecast, by Country 14.14.1. Germany 14.14.2. U.K. 14.14.3. France 14.14.4. Italy 14.14.5. Spain 14.14.6. Rest of Europe 14.15. Europe Precision Medicine Market Analysis, by Country 14.16. Germany Precision Medicine Market Forecast, By Product types 14.16.1. Instruments 14.16.2. Consumables 14.16.3. Services 14.17. Germany Precision Medicine Market Forecast, By Technology Type 14.17.1. Transcriptomics 14.17.2. Genomic Sequencing 14.17.3. Epigenomics 14.17.4. Bioinformatics 14.17.5. Drug Discovery 14.17.6. Companion Diagnostics 14.17.7. Big Data Analytics Software 14.17.8. Other Technologies 14.18. Germany Precision Medicine Market Forecast, By Sequencing Technology type 14.18.1. Ion Semiconductor Sequencing 14.18.2. Pyrosequencing 14.18.3. Single Molecule Real Time Sequencing 14.18.4. Chain Termination Sequencing 14.18.5. Sequencing by Synthesis 14.18.6. Sequencing by Ligation 14.18.7. Nanopore Sequencing 14.19. Germany Precision Medicine Market Forecast, By Application Type 14.19.1. Oncology 14.19.2. Immunology 14.19.3. CNS 14.19.4. Respiratory 14.19.5. Neurosciences 14.19.6. Infections 14.19.7. Pharmacogenomics 14.19.8. Rare Diseases 14.19.9. Other 14.20. GermanyPrecision Medicine Market Forecast, By End User 14.20.1. Pharma & Biotech Companies 14.20.2. Diagnostic Tool Companies 14.20.3. Big Data Companies 14.20.4. Clinical Laboratories 14.20.5. Healthcare Providers 14.20.6. Research Centers and Academic Institutes 14.20.7. Other 14.21. U.K. Precision Medicine Market Forecast, By Product types 14.21.1. Instruments 14.21.2. Consumables 14.21.3. Services 14.22. U.K. Precision Medicine Market Forecast, By Technology Type 14.22.1. Transcriptomics 14.22.2. Genomic Sequencing 14.22.3. Epigenomics 14.22.4. Bioinformatics 14.22.5. Drug Discovery 14.22.6. Companion Diagnostics 14.22.7. Big Data Analytics Software 14.22.8. Other Technologies 14.23. U.K. Precision Medicine Market Forecast, By Sequencing Technology type 14.23.1. Ion Semiconductor Sequencing 14.23.2. Pyrosequencing 14.23.3. Single Molecule Real Time Sequencing 14.23.4. Chain Termination Sequencing 14.23.5. Sequencing by Synthesis 14.23.6. Sequencing by Ligation 14.23.7. Nanopore Sequencing 14.24. U.K. Precision Medicine Market Forecast, By Application Type 14.24.1. Oncology 14.24.2. Immunology 14.24.3. CNS 14.24.4. Respiratory 14.24.5. Neurosciences 14.24.6. Infections 14.24.7. Pharmacogenomics 14.24.8. Rare Diseases 14.24.9. Other 14.25. U.K. Precision Medicine Market Forecast, By End User 14.25.1. Pharma & Biotech Companies 14.25.2. Diagnostic Tool Companies 14.25.3. Big Data Companies 14.25.4. Clinical Laboratories 14.25.5. Healthcare Providers 14.25.6. Research Centers and Academic Institutes 14.25.7. Other 14.26. France Precision Medicine Market Forecast, By Product types 14.26.1. Instruments 14.26.2. Consumables 14.26.3. Services 14.27. France Precision Medicine Market Forecast, By Technology Type 14.27.1. Transcriptomics 14.27.2. Genomic Sequencing 14.27.3. Epigenomics 14.27.4. Bioinformatics 14.27.5. Drug Discovery 14.27.6. Companion Diagnostics 14.27.7. Big Data Analytics Software 14.27.8. Other Technologies 14.28. France Precision Medicine Market Forecast, By Sequencing Technology type 14.28.1. Ion Semiconductor Sequencing 14.28.2. Pyrosequencing 14.28.3. Single Molecule Real Time Sequencing 14.28.4. Chain Termination Sequencing 14.28.5. Sequencing by Synthesis 14.28.6. Sequencing by Ligation 14.28.7. Nanopore Sequencing 14.29. France Precision Medicine Market Forecast, By Application Type 14.29.1. Oncology 14.29.2. Immunology 14.29.3. CNS 14.29.4. Respiratory 14.29.5. Neurosciences 14.29.6. Infections 14.29.7. Pharmacogenomics 14.29.8. Rare Diseases 14.29.9. Other 14.30. FrancePrecision Medicine Market Forecast, By End User 14.30.1. Pharma & Biotech Companies 14.30.2. Diagnostic Tool Companies 14.30.3. Big Data Companies 14.30.4. Clinical Laboratories 14.30.5. Healthcare Providers 14.30.6. Research Centers and Academic Institutes 14.30.7. Other 14.31. Italy Precision Medicine Market Forecast, By Product types 14.31.1. Instruments 14.31.2. Consumables 14.31.3. Services 14.32. Italy Precision Medicine Market Forecast, By Technology Type 14.32.1. Transcriptomics 14.32.2. Genomic Sequencing 14.32.3. Epigenomics 14.32.4. Bioinformatics 14.32.5. Drug Discovery 14.32.6. Companion Diagnostics 14.32.7. Big Data Analytics Software 14.32.8. Other Technologies 14.33. Italy Precision Medicine Market Forecast, By Sequencing Technology type 14.33.1. Ion Semiconductor Sequencing 14.33.2. Pyrosequencing 14.33.3. Single Molecule Real Time Sequencing 14.33.4. Chain Termination Sequencing 14.33.5. Sequencing by Synthesis 14.33.6. Sequencing by Ligation 14.33.7. Nanopore Sequencing 14.34. Italy Precision Medicine Market Forecast, By Application Type 14.34.1. Oncology 14.34.2. Immunology 14.34.3. CNS 14.34.4. Respiratory 14.34.5. Neurosciences 14.34.6. Infections 14.34.7. Pharmacogenomics 14.34.8. Rare Diseases 14.34.9. Other 14.35. Italy Precision Medicine Market Forecast, By End User 14.35.1. Pharma & Biotech Companies 14.35.2. Diagnostic Tool Companies 14.35.3. Big Data Companies 14.35.4. Clinical Laboratories 14.35.5. Healthcare Providers 14.35.6. Research Centers and Academic Institutes 14.35.7. Other 14.36. Spain Precision Medicine Market Forecast, By Product types 14.36.1. Instruments 14.36.2. Consumables 14.36.3. Services 14.37. Spain Precision Medicine Market Forecast, By Technology Type 14.37.1. Transcriptomics 14.37.2. Genomic Sequencing 14.37.3. Epigenomics 14.37.4. Bioinformatics 14.37.5. Drug Discovery 14.37.6. Companion Diagnostics 14.37.7. Big Data Analytics Software 14.37.8. Other Technologies 14.38. Spain Precision Medicine Market Forecast, By Sequencing Technology type 14.38.1. Ion Semiconductor Sequencing 14.38.2. Pyrosequencing 14.38.3. Single Molecule Real Time Sequencing 14.38.4. Chain Termination Sequencing 14.38.5. Sequencing by Synthesis 14.38.6. Sequencing by Ligation 14.38.7. Nanopore Sequencing 14.39. Spain Precision Medicine Market Forecast, By Application Type 14.39.1. Oncology 14.39.2. Immunology 14.39.3. CNS 14.39.4. Respiratory 14.39.5. Neurosciences 14.39.6. Infections 14.39.7. Pharmacogenomics 14.39.8. Rare Diseases 14.39.9. Other 14.40. Spain Precision Medicine Market Forecast, By End User 14.40.1. Pharma & Biotech Companies 14.40.2. Diagnostic Tool Companies 14.40.3. Big Data Companies 14.40.4. Clinical Laboratories 14.40.5. Healthcare Providers 14.40.6. Research Centers and Academic Institutes 14.40.7. Other 14.41. Rest of Europe Precision Medicine Market Forecast, By Product types 14.41.1. Instruments 14.41.2. Consumables 14.41.3. Services 14.42. Rest of Europe Precision Medicine Market Forecast, By Technology Type 14.42.1. Transcriptomics 14.42.2. Genomic Sequencing 14.42.3. Epigenomics 14.42.4. Bioinformatics 14.42.5. Drug Discovery 14.42.6. Companion Diagnostics 14.42.7. Big Data Analytics Software 14.42.8. Other Technologies 14.43. Rest Of Europe Precision Medicine Market Forecast, By Sequencing Technology type 14.43.1. Ion Semiconductor Sequencing 14.43.2. Pyrosequencing 14.43.3. Single Molecule Real Time Sequencing 14.43.4. Chain Termination Sequencing 14.43.5. Sequencing by Synthesis 14.43.6. Sequencing by Ligation 14.43.7. Nanopore Sequencing 14.44. Rest of Europe Precision Medicine Market Forecast, By Application Type 14.44.1. Oncology 14.44.2. Immunology 14.44.3. CNS 14.44.4. Respiratory 14.44.5. Neurosciences 14.44.6. Infections 14.44.7. Pharmacogenomics 14.44.8. Rare Diseases 14.44.9. Other 14.45. Rest of Europe. Precision Medicine Market Forecast, By End User 14.45.1. Pharma & Biotech Companies 14.45.2. Diagnostic Tool Companies 14.45.3. Big Data Companies 14.45.4. Clinical Laboratories 14.45.5. Healthcare Providers 14.45.6. Research Centers and Academic Institutes 14.45.7. Other 14.46. Europe Precision Medicine Market Attractiveness Analysis 14.46.1. By Product types 14.46.2. By Technology Type 14.46.3. By Sequencing Technology type 14.46.4. By Application Type 14.46.5. By End User 14.47. PEST Analysis 14.48. Key Trends 14.49. Key Developments 15. Asia Pacific Precision Medicine Market Analysis 15.1. Key Findings 15.2. Asia Pacific Precision Medicine Market Overview 15.3. Asia Pacific Precision Medicine Market Value Share Analysis, By Product types 15.4. Asia Pacific Precision Medicine Market Forecast, By Product types 15.4.1. Instruments 15.4.2. Consumables 15.4.3. Services 15.5. Asia Pacific Precision Medicine Market Value Share Analysis, By Technology Type 15.6. Asia Pacific Precision Medicine Market Forecast, By Technology Type 15.6.1. Transcriptomics 15.6.2. Genomic Sequencing 15.6.3. Epigenomics 15.6.4. Bioinformatics 15.6.5. Drug Discovery 15.6.6. Companion Diagnostics 15.6.7. Big Data Analytics Software 15.6.8. Other Technologies 15.7. Asia Pacific Precision Medicine Market Value Share Analysis, By Sequencing Technology type 15.8. Asia Pacific Precision Medicine Market Forecast, By Sequencing Technology type 15.8.1. Ion Semiconductor Sequencing 15.8.2. Pyrosequencing 15.8.3. Single Molecule Real Time Sequencing 15.8.4. Chain Termination Sequencing 15.8.5. Sequencing by Synthesis 15.8.6. Sequencing by Ligation 15.8.7. Nanopore Sequencing 15.9. Asia Pacific Precision Medicine Market Value Share Analysis, By Application Type 15.10. North America Precision Medicine Market Forecast, By Application Type 15.10.1. Oncology 15.10.2. Immunology 15.10.3. CNS 15.10.4. Respiratory 15.10.5. Neurosciences 15.10.6. Infections 15.10.7. Pharmacogenomics 15.10.8. Rare Diseases 15.10.9. Other 15.11. Asia Pacific Precision Medicine Market Value Share Analysis, By End User 15.12. North America Precision Medicine Market Forecast, By End User 15.12.1. Pharma & Biotech Companies 15.12.2. Diagnostic Tool Companies 15.12.3. Big Data Companies 15.12.4. Clinical Laboratories 15.12.5. Healthcare Providers 15.12.6. Research Centers and Academic Institutes 15.12.7. Other 15.13. Asia Pacific Precision Medicine Market Value Share Analysis, by Country 15.14. Asia Pacific Precision Medicine Market Forecast, by Country 15.14.1. China 15.14.2. India 15.14.3. Japan 15.14.4. ASEAN 15.14.5. Rest of Asia Pacific 15.15. Asia Pacific Precision Medicine Market Analysis, by Country 15.16. China Precision Medicine Market Forecast, By Product types 15.16.1. Instruments 15.16.2. Consumables 15.16.3. Services 15.17. China Precision Medicine Market Forecast, By Technology Type 15.17.1. Transcriptomics 15.17.2. Genomic Sequencing 15.17.3. Epigenomics 15.17.4. Bioinformatics 15.17.5. Drug Discovery 15.17.6. Companion Diagnostics 15.17.7. Big Data Analytics Software 15.17.8. Other Technologies 15.18. China Precision Medicine Market Forecast, By Sequencing Technology type 15.18.1. Ion Semiconductor Sequencing 15.18.2. Pyrosequencing 15.18.3. Single Molecule Real Time Sequencing 15.18.4. Chain Termination Sequencing 15.18.5. Sequencing by Synthesis 15.18.6. Sequencing by Ligation 15.18.7. Nanopore Sequencing 15.19. China. Precision Medicine Market Forecast, By Application Type 15.19.1. Oncology 15.19.2. Immunology 15.19.3. CNS 15.19.4. Respiratory 15.19.5. Neurosciences 15.19.6. Infections 15.19.7. Pharmacogenomics 15.19.8. Rare Diseases 15.19.9. Other 15.20. China Precision Medicine Market Forecast, By End User 15.20.1. Pharma & Biotech Companies 15.20.2. Diagnostic Tool Companies 15.20.3. Big Data Companies 15.20.4. Clinical Laboratories 15.20.5. Healthcare Providers 15.20.6. Research Centers and Academic Institutes 15.20.7. Other 15.21. India Precision Medicine Market Forecast, By Product types 15.21.1. Instruments 15.21.2. Consumables 15.21.3. Services 15.22. India Precision Medicine Market Forecast, By Technology Type 15.22.1. Transcriptomics 15.22.2. Genomic Sequencing 15.22.3. Epigenomics 15.22.4. Bioinformatics 15.22.5. Drug Discovery 15.22.6. Companion Diagnostics 15.22.7. Big Data Analytics Software 15.22.8. Other Technologies 15.23. India Precision Medicine Market Forecast, By Sequencing Technology type 15.23.1. Ion Semiconductor Sequencing 15.23.2. Pyrosequencing 15.23.3. Single Molecule Real Time Sequencing 15.23.4. Chain Termination Sequencing 15.23.5. Sequencing by Synthesis 15.23.6. Sequencing by Ligation 15.23.7. Nanopore Sequencing 15.24. India Precision Medicine Market Forecast, By Application Type 15.24.1. Oncology 15.24.2. Immunology 15.24.3. CNS 15.24.4. Respiratory 15.24.5. Neurosciences 15.24.6. Infections 15.24.7. Pharmacogenomics 15.24.8. Rare Diseases 15.24.9. Other 15.25. India Precision Medicine Market Forecast, By End User 15.25.1. Pharma & Biotech Companies 15.25.2. Diagnostic Tool Companies 15.25.3. Big Data Companies 15.25.4. Clinical Laboratories 15.25.5. Healthcare Providers 15.25.6. Research Centers and Academic Institutes 15.25.7. Other 15.26. Japan Precision Medicine Market Forecast, By Product types 15.26.1. Instruments 15.26.2. Consumables 15.26.3. Services 15.27. Japan Precision Medicine Market Forecast, By Technology Type 15.27.1. Transcriptomics 15.27.2. Genomic Sequencing 15.27.3. Epigenomics 15.27.4. Bioinformatics 15.27.5. Drug Discovery 15.27.6. Companion Diagnostics 15.27.7. Big Data Analytics Software 15.27.8. Other Technologies 15.28. Japan Precision Medicine Market Forecast, By Sequencing Technology type 15.28.1. Ion Semiconductor Sequencing 15.28.2. Pyrosequencing 15.28.3. Single Molecule Real Time Sequencing 15.28.4. Chain Termination Sequencing 15.28.5. Sequencing by Synthesis 15.28.6. Sequencing by Ligation 15.28.7. Nanopore Sequencing 15.29. Japan Precision Medicine Market Forecast, By Application Type 15.29.1. Oncology 15.29.2. Immunology 15.29.3. CNS 15.29.4. Respiratory 15.29.5. Neurosciences 15.29.6. Infections 15.29.7. Pharmacogenomics 15.29.8. Rare Diseases 15.29.9. Other 15.30. Japan Precision Medicine Market Forecast, By End User 15.30.1. Pharma & Biotech Companies 15.30.2. Diagnostic Tool Companies 15.30.3. Big Data Companies 15.30.4. Clinical Laboratories 15.30.5. Healthcare Providers 15.30.6. Research Centers and Academic Institutes 15.30.7. Other 15.31. ASEAN Precision Medicine Market Forecast, By Product types 15.31.1. Instruments 15.31.2. Consumables 15.31.3. Services 15.32. ASEAN Precision Medicine Market Forecast, By Technology Type 15.32.1. Transcriptomics 15.32.2. Genomic Sequencing 15.32.3. Epigenomics 15.32.4. Bioinformatics 15.32.5. Drug Discovery 15.32.6. Companion Diagnostics 15.32.7. Big Data Analytics Software 15.32.8. Other Technologies 15.33. ASEAN Precision Medicine Market Forecast, By Sequencing Technology type 15.33.1. Ion Semiconductor Sequencing 15.33.2. Pyrosequencing 15.33.3. Single Molecule Real Time Sequencing 15.33.4. Chain Termination Sequencing 15.33.5. Sequencing by Synthesis 15.33.6. Sequencing by Ligation 15.33.7. Nanopore Sequencing 15.34. ASEAN Precision Medicine Market Forecast, By Application Type 15.34.1. Oncology 15.34.2. Immunology 15.34.3. CNS 15.34.4. Respiratory 15.34.5. Neurosciences 15.34.6. Infections 15.34.7. Pharmacogenomics 15.34.8. Rare Diseases 15.34.9. Other 15.35. ASEAN Precision Medicine Market Forecast, By End User 15.35.1. Pharma & Biotech Companies 15.35.2. Diagnostic Tool Companies 15.35.3. Big Data Companies 15.35.4. Clinical Laboratories 15.35.5. Healthcare Providers 15.35.6. Research Centers and Academic Institutes 15.35.7. Other 15.36. Rest of Asia Pacific Precision Medicine Market Forecast, By Product types 15.36.1. Instruments 15.36.2. Consumables 15.36.3. Services 15.37. Rest of Asia Pacific Precision Medicine Market Forecast, By Technology Type 15.37.1. Transcriptomics 15.37.2. Genomic Sequencing 15.37.3. Epigenomics 15.37.4. Bioinformatics 15.37.5. Drug Discovery 15.37.6. Companion Diagnostics 15.37.7. Big Data Analytics Software 15.37.8. Other Technologies 15.38. Rest of Asia Pacific Precision Medicine Market Forecast, By Sequencing Technology type 15.38.1. Ion Semiconductor Sequencing 15.38.2. Pyrosequencing 15.38.3. Single Molecule Real Time Sequencing 15.38.4. Chain Termination Sequencing 15.38.5. Sequencing by Synthesis 15.38.6. Sequencing by Ligation 15.38.7. Nanopore Sequencing 15.39. Rest of Asia Precision Medicine Market Forecast, By Application Type 15.39.1. Oncology 15.39.2. Immunology 15.39.3. CNS 15.39.4. Respiratory 15.39.5. Neurosciences 15.39.6. Infections 15.39.7. Pharmacogenomics 15.39.8. Rare Diseases 15.39.9. Other 15.40. Rest of Asia Precision Medicine Market Forecast, By End User 15.40.1. Pharma & Biotech Companies 15.40.2. Diagnostic Tool Companies 15.40.3. Big Data Companies 15.40.4. Clinical Laboratories 15.40.5. Healthcare Providers 15.40.6. Research Centers and Academic Institutes 15.40.7. Other 15.41. Asia Pacific Precision Medicine Market Attractiveness Analysis 15.41.1. By Product types 15.41.2. By Technology Type 15.41.3. By Sequencing Technology type 15.41.4. By Application Type 15.41.5. By End User 15.42. PEST Analysis 15.43. Key Trends 15.44. Key Developments 16. Middle East & Africa Precision Medicine Market Analysis 16.1. Key Findings 16.2. Middle East & Africa Precision Medicine Market Overview 16.3. Middle East & Africa Precision Medicine Market Value Share Analysis, By Product types 16.4. Middle East & Africa Precision Medicine Market Forecast, By Product types 16.4.1. Instruments 16.4.2. Consumables 16.4.3. Services 16.5. Middle East & Africa Precision Medicine Market Value Share Analysis, By Technology Type 16.6. Middle East & Africa Precision Medicine Market Forecast, By Technology Type 16.6.1. Transcriptomics 16.6.2. Genomic Sequencing 16.6.3. Epigenomics 16.6.4. Bioinformatics 16.6.5. Drug Discovery 16.6.6. Companion Diagnostics 16.6.7. Big Data Analytics Software 16.6.8. Other Technologies 16.7. Middle East & Africa Precision Medicine Market Value Share Analysis, By Sequencing Technology type 16.8. Middle East & Africa Precision Medicine Market Forecast, By Sequencing Technology type 16.8.1. Ion Semiconductor Sequencing 16.8.2. Pyrosequencing 16.8.3. Single Molecule Real Time Sequencing 16.8.4. Chain Termination Sequencing 16.8.5. Sequencing by Synthesis 16.8.6. Sequencing by Ligation 16.8.7. Nanopore Sequencing 16.9. Middle East & Africa Precision Medicine Market Value Share Analysis, By Application Type 16.10. North America Precision Medicine Market Forecast, By Application Type 16.10.1. Oncology 16.10.2. Immunology 16.10.3. CNS 16.10.4. Respiratory 16.10.5. Neurosciences 16.10.6. Infections 16.10.7. Pharmacogenomics 16.10.8. Rare Diseases 16.10.9. Other 16.11. Middle East & Africa North America Precision Medicine Market Value Share Analysis, By End User 16.12. North America Precision Medicine Market Forecast, By End User 16.12.1. Pharma & Biotech Companies 16.12.2. Diagnostic Tool Companies 16.12.3. Big Data Companies 16.12.4. Clinical Laboratories 16.12.5. Healthcare Providers 16.12.6. Research Centers and Academic Institutes 16.12.7. Other 16.13. Middle East & Africa Precision Medicine Market Value Share Analysis, by Country 16.14. Middle East & Africa Precision Medicine Market Forecast, by Country 16.14.1. GCC 16.14.2. South Africa 16.14.3. Rest of Middle East & Africa 16.15. Middle East & Africa Precision Medicine Market Analysis, by Country 16.16. GCC Precision Medicine Market Forecast, By Product types 16.16.1. Instruments 16.16.2. Consumables 16.16.3. Services 16.17. GCC Precision Medicine Market Forecast, By Technology Type 16.17.1. Transcriptomics 16.17.2. Genomic Sequencing 16.17.3. Epigenomics 16.17.4. Bioinformatics 16.17.5. Drug Discovery 16.17.6. Companion Diagnostics 16.17.7. Big Data Analytics Software 16.17.8. Other Technologies 16.18. GCC Precision Medicine Market Forecast, By Sequencing Technology type 16.18.1. Ion Semiconductor Sequencing 16.18.2. Pyrosequencing 16.18.3. Single Molecule Real Time Sequencing 16.18.4. Chain Termination Sequencing 16.18.5. Sequencing by Synthesis 16.18.6. Sequencing by Ligation 16.18.7. Nanopore Sequencing 16.19. GCC U.S. Precision Medicine Market Forecast, By Application Type 16.19.1. Oncology 16.19.2. Immunology 16.19.3. CNS 16.19.4. Respiratory 16.19.5. Neurosciences 16.19.6. Infections 16.19.7. Pharmacogenomics 16.19.8. Rare Diseases 16.19.9. Other 16.20. GCC Precision Medicine Market Forecast, By End User 16.20.1. Pharma & Biotech Companies 16.20.2. Diagnostic Tool Companies 16.20.3. Big Data Companies 16.20.4. Clinical Laboratories 16.20.5. Healthcare Providers 16.20.6. Research Centers and Academic Institutes 16.20.7. Other 16.21. South Africa Precision Medicine Market Forecast, By Product types 16.21.1. Instruments 16.21.2. Consumables 16.21.3. Services 16.22. South Africa Precision Medicine Market Forecast, By Technology Type 16.22.1. Transcriptomics 16.22.2. Genomic Sequencing 16.22.3. Epigenomics 16.22.4. Bioinformatics 16.22.5. Drug Discovery 16.22.6. Companion Diagnostics 16.22.7. Big Data Analytics Software 16.22.8. Other Technologies 16.23. South Africa Precision Medicine Market Forecast, By Sequencing Technology type 16.23.1. Ion Semiconductor Sequencing 16.23.2. Pyrosequencing 16.23.3. Single Molecule Real Time Sequencing 16.23.4. Chain Termination Sequencing 16.23.5. Sequencing by Synthesis 16.23.6. Sequencing by Ligation 16.23.7. Nanopore Sequencing 16.24. South Africa Precision Medicine Market Forecast, By Application Type 16.24.1. Oncology 16.24.2. Immunology 16.24.3. CNS 16.24.4. Respiratory 16.24.5. Neurosciences 16.24.6. Infections 16.24.7. Pharmacogenomics 16.24.8. Rare Diseases 16.24.9. Other 16.25. South Africa U.S. Precision Medicine Market Forecast, By End User 16.25.1. Pharma & Biotech Companies 16.25.2. Diagnostic Tool Companies 16.25.3. Big Data Companies 16.25.4. Clinical Laboratories 16.25.5. Healthcare Providers 16.25.6. Research Centers and Academic Institutes 16.25.7. Other 16.26. Rest of Middle East & Africa Precision Medicine Market Forecast, By Product types 16.26.1. Instruments 16.26.2. Consumables 16.26.3. Services 16.27. Rest of Middle East & Africa Precision Medicine Market Forecast, By Technology Type 16.27.1. Transcriptomics 16.27.2. Genomic Sequencing 16.27.3. Epigenomics 16.27.4. Bioinformatics 16.27.5. Drug Discovery 16.27.6. Companion Diagnostics 16.27.7. Big Data Analytics Software 16.27.8. Other Technologies 16.28. Middle East & Africa Precision Medicine Market Forecast, By Sequencing Technology type 16.28.1. Ion Semiconductor Sequencing 16.28.2. Pyrosequencing 16.28.3. Single Molecule Real Time Sequencing 16.28.4. Chain Termination Sequencing 16.28.5. Sequencing by Synthesis 16.28.6. Sequencing by Ligation 16.28.7. Nanopore Sequencing 16.29. Rest of Middle East & Africa Precision Medicine Market Forecast, By Application Type 16.29.1. Oncology 16.29.2. Immunology 16.29.3. CNS 16.29.4. Respiratory 16.29.5. Neurosciences 16.29.6. Infections 16.29.7. Pharmacogenomics 16.29.8. Rare Diseases 16.29.9. Other 16.30. Rest of Middle East & Africa Precision Medicine Market Forecast, By End User 16.30.1. Pharma & Biotech Companies 16.30.2. Diagnostic Tool Companies 16.30.3. Big Data Companies 16.30.4. Clinical Laboratories 16.30.5. Healthcare Providers 16.30.6. Research Centers and Academic Institutes 16.30.7. Other 16.31. Middle East & Africa Precision Medicine Market Attractiveness Analysis 16.31.1. By Product types 16.31.2. By Technology Type 16.31.3. By Sequencing Technology type 16.31.4. By Application Type 16.31.5. By End User 16.32. PEST Analysis 16.33. Key Trends 16.34. Key Developments 17. South America Precision Medicine Market Analysis 17.1. Key Findings 17.2. South America Precision Medicine Market Overview 17.3. South America Precision Medicine Market Value Share Analysis, By Product types 17.4. South America Precision Medicine Market Forecast, By Product types 17.4.1. Instruments 17.4.2. Consumables 17.4.3. Services 17.5. South America Precision Medicine Market Value Share Analysis, By Technology Type 17.6. South America Precision Medicine Market Forecast, By Technology Type 17.6.1. Transcriptomics 17.6.2. Genomic Sequencing 17.6.3. Epigenomics 17.6.4. Bioinformatics 17.6.5. Drug Discovery 17.6.6. Companion Diagnostics 17.6.7. Big Data Analytics Software 17.6.8. Other Technologies 17.7. South America Precision Medicine Market Value Share Analysis, By Sequencing Technology type 17.8. South America Precision Medicine Market Forecast, By Sequencing Technology type 17.8.1. Ion Semiconductor Sequencing 17.8.2. Pyrosequencing 17.8.3. Single Molecule Real Time Sequencing 17.8.4. Chain Termination Sequencing 17.8.5. Sequencing by Synthesis 17.8.6. Sequencing by Ligation 17.8.7. Nanopore Sequencing 17.9. South America Precision Medicine Market Value Share Analysis, By Application Type 17.10. South America Precision Medicine Market Forecast, By Application Type 17.10.1. Oncology 17.10.2. Immunology 17.10.3. CNS 17.10.4. Respiratory 17.10.5. Neurosciences 17.10.6. Infections 17.10.7. Pharmacogenomics 17.10.8. Rare Diseases 17.10.9. Other 17.11. South America Precision Medicine Market Value Share Analysis, By End User 17.12. South America Precision Medicine Market Forecast, By End User 17.12.1. Pharma & Biotech Companies 17.12.2. Diagnostic Tool Companies 17.12.3. Big Data Companies 17.12.4. Clinical Laboratories 17.12.5. Healthcare Providers 17.12.6. Research Centers and Academic Institutes 17.12.7. Other 17.13. South America Precision Medicine Market Value Share Analysis, by Country 17.14. South America Precision Medicine Market Forecast, by Country 17.14.1. Brazil 17.14.2. Mexico 17.14.3. Rest of South America 17.15. South America Precision Medicine Market Analysis, by Country 17.16. Brazil Precision Medicine Market Forecast, By Product types 17.16.1. Instruments 17.16.2. Consumables 17.16.3. Services 17.17. Brazil Precision Medicine Market Forecast, By Technology Type 17.17.1. Transcriptomics 17.17.2. Genomic Sequencing 17.17.3. Epigenomics 17.17.4. Bioinformatics 17.17.5. Drug Discovery 17.17.6. Companion Diagnostics 17.17.7. Big Data Analytics Software 17.17.8. Other Technologies 17.18. Brazil Precision Medicine Market Forecast, By Sequencing Technology type 17.18.1. Ion Semiconductor Sequencing 17.18.2. Pyrosequencing 17.18.3. Single Molecule Real Time Sequencing 17.18.4. Chain Termination Sequencing 17.18.5. Sequencing by Synthesis 17.18.6. Sequencing by Ligation 17.18.7. Nanopore Sequencing 17.19. Brazil Precision Medicine Market Forecast, By Application Type 17.19.1. Oncology 17.19.2. Immunology 17.19.3. CNS 17.19.4. Respiratory 17.19.5. Neurosciences 17.19.6. Infections 17.19.7. Pharmacogenomics 17.19.8. Rare Diseases 17.19.9. Other 17.20. Brazil. Precision Medicine Market Forecast, By End User 17.20.1. Pharma & Biotech Companies 17.20.2. Diagnostic Tool Companies 17.20.3. Big Data Companies 17.20.4. Clinical Laboratories 17.20.5. Healthcare Providers 17.20.6. Research Centers and Academic Institutes 17.20.7. Other 17.21. Mexico Precision Medicine Market Forecast, By Product types 17.21.1. Instruments 17.21.2. Consumables 17.21.3. Services 17.22. Mexico Precision Medicine Market Forecast, By Technology Type 17.22.1. Transcriptomics 17.22.2. Genomic Sequencing 17.22.3. Epigenomics 17.22.4. Bioinformatics 17.22.5. Drug Discovery 17.22.6. Companion Diagnostics 17.22.7. Big Data Analytics Software 17.22.8. Other Technologies 17.23. Mexico Precision Medicine Market Forecast, By Sequencing Technology type 17.23.1. Ion Semiconductor Sequencing 17.23.2. Pyrosequencing 17.23.3. Single Molecule Real Time Sequencing 17.23.4. Chain Termination Sequencing 17.23.5. Sequencing by Synthesis 17.23.6. Sequencing by Ligation 17.23.7. Nanopore Sequencing 17.24. Mexico Precision Medicine Market Forecast, By Application Type 17.24.1. Oncology 17.24.2. Immunology 17.24.3. CNS 17.24.4. Respiratory 17.24.5. Neurosciences 17.24.6. Infections 17.24.7. Pharmacogenomics 17.24.8. Rare Diseases 17.24.9. Other 17.25. Mexico Precision Medicine Market Forecast, By End User 17.25.1. Pharma & Biotech Companies 17.25.2. Diagnostic Tool Companies 17.25.3. Big Data Companies 17.25.4. Clinical Laboratories 17.25.5. Healthcare Providers 17.25.6. Research Centers and Academic Institutes 17.25.7. Other 17.26. Rest of South America Precision Medicine Market Forecast, By Product types 17.26.1. Instruments 17.26.2. Consumables 17.26.3. Services 17.27. Rest of South America Precision Medicine Market Forecast, By Technology Type 17.27.1. Transcriptomics 17.27.2. Genomic Sequencing 17.27.3. Epigenomics 17.27.4. Bioinformatics 17.27.5. Drug Discovery 17.27.6. Companion Diagnostics 17.27.7. Big Data Analytics Software 17.27.8. Other Technologies 17.28. Rest of South America Precision Medicine Market Forecast, By Sequencing Technology type 17.28.1. Ion Semiconductor Sequencing 17.28.2. Pyrosequencing 17.28.3. Single Molecule Real Time Sequencing 17.28.4. Chain Termination Sequencing 17.28.5. Sequencing by Synthesis 17.28.6. Sequencing by Ligation 17.28.7. Nanopore Sequencing 17.29. Rest of South America Precision Medicine Market Forecast, By Application Type 17.29.1. Oncology 17.29.2. Immunology 17.29.3. CNS 17.29.4. Respiratory 17.29.5. Neurosciences 17.29.6. Infections 17.29.7. Pharmacogenomics 17.29.8. Rare Diseases 17.29.9. Other 17.30. Rest of South America Precision Medicine Market Forecast, By End User 17.30.1. Pharma & Biotech Companies 17.30.2. Diagnostic Tool Companies 17.30.3. Big Data Companies 17.30.4. Clinical Laboratories 17.30.5. Healthcare Providers 17.30.6. Research Centers and Academic Institutes 17.30.7. Other 17.31. South America Precision Medicine Market Attractiveness Analysis 17.31.1. By Product types 17.31.2. By Technology Type 17.31.3. By Sequencing Technology type 17.31.4. By Application Type 17.31.5. By End User 17.32. PEST Analysis 17.33. Key Trends 17.34. Key Developments 18. Company Profiles 18.1. Market Share Analysis, by Company 18.2. Competition Matrix 18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 18.2.2. New Product Launches and Product Enhancements 18.2.3. Market Consolidation 18.2.3.1. M&A by Regions, Investment and Applications 18.2.3.2. M&A Key Players, Forward Integration and Backward 18.2.3.3. Integration 18.3. Company Profiles: Key Players 18.3.1. ASEBIO 18.3.1.1. Company Overview 18.3.1.2. Financial Overview 18.3.1.3. Product Portfolio 18.3.1.4. Business Strategy 18.3.1.5. Recent Developments 18.3.1.6. Development Footprint 18.3.2. Biocrates Life Sciences AG 18.3.3. DxTerity Diagnostics Inc. 18.3.4. DxTerity Diagnostics Inc. 18.3.5. F. Hoffmann-La Roche Ltd 18.3.6. FOUNDATION MEDICINE 18.3.7. Intomics 18.3.8. Laboratory Corporation of America Holdings 18.3.9. Menarini Silicon Biosystems 18.3.10. NanoString Technologies, Inc 18.3.11. NeoGenomics Laboratories 18.3.12. Novartis AG 18.3.13. Pfizer Inc 18.3.14. QIAGEN 18.3.15. Quest Diagnostics Incorporated 18.3.16. Tepnel Pharma Services (Hologic Inc.) 18.3.17. Teva Pharmaceutical 18.3.18. Randox Laboratories 18.3.19. Biomrieux Sa 18.3.20. Abbott Laboratories 18.3.21. Intel Corporation 18.3.22. Cepheid 19. Primary Key Insights